title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Stocks That Hit 52-Week Lows On Wednesday,20220511T162815,https://www.benzinga.com/markets/options/22/05/27141482/52-weeks-high-and-low-article,MRSN,0.006905,Bearish,-0.374918
Stocks That Hit 52-Week Lows On Thursday,20220428T193101,https://www.benzinga.com/markets/options/22/04/26872967/52-weeks-high-and-low-article,MRSN,0.00644,Neutral,-0.00039
"The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More",20220414T133544,https://www.benzinga.com/general/biotech/22/04/26630399/the-daily-biotech-pulse-pfizer-biontech-covid-19-booster-data-in-kids-regenerons-covid-19-therapy,MRSN,0.08395,Neutral,-9.4e-05
"Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger - Pyxis Oncology  ( NASDAQ:PYXS ) , Syndax Pharmaceuticals  ( NASDAQ:SNDX ) ",20240610T113000,https://www.benzinga.com/pressreleases/24/06/g39247597/pyxis-oncology-expands-board-of-directors-with-appointment-of-michael-a-metzger,MRSN,0.044222,Neutral,0.0
Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger,20240610T113000,https://www.globenewswire.com/news-release/2024/06/10/2895898/0/en/Pyxis-Oncology-Expands-Board-of-Directors-with-Appointment-of-Michael-A-Metzger.html,MRSN,0.046633,Neutral,0.0
68 Biggest Movers From Yesterday,20220419T083535,https://www.benzinga.com/news/22/04/26681653/68-biggest-movers-from-yesterday,MRSN,0.085416,Neutral,0.001752
34 Stocks Moving In Monday's Mid-Day Session,20220418T161356,https://www.benzinga.com/news/22/04/26671086/34-stocks-moving-in-mondays-mid-day-session,MRSN,0.165069,Neutral,0.000478
